1. Home
  2. COLM vs SWTX Comparison

COLM vs SWTX Comparison

Compare COLM & SWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COLM
  • SWTX
  • Stock Information
  • Founded
  • COLM 1938
  • SWTX 2017
  • Country
  • COLM United States
  • SWTX United States
  • Employees
  • COLM N/A
  • SWTX N/A
  • Industry
  • COLM Apparel
  • SWTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • COLM Consumer Discretionary
  • SWTX Health Care
  • Exchange
  • COLM Nasdaq
  • SWTX Nasdaq
  • Market Cap
  • COLM 3.5B
  • SWTX 3.5B
  • IPO Year
  • COLM 1998
  • SWTX 2019
  • Fundamental
  • Price
  • COLM $60.39
  • SWTX $46.96
  • Analyst Decision
  • COLM Hold
  • SWTX Buy
  • Analyst Count
  • COLM 6
  • SWTX 7
  • Target Price
  • COLM $68.00
  • SWTX $56.86
  • AVG Volume (30 Days)
  • COLM 655.3K
  • SWTX 4.9M
  • Earning Date
  • COLM 07-24-2025
  • SWTX 08-06-2025
  • Dividend Yield
  • COLM 1.99%
  • SWTX N/A
  • EPS Growth
  • COLM N/A
  • SWTX N/A
  • EPS
  • COLM 3.88
  • SWTX N/A
  • Revenue
  • COLM $3,377,052,000.00
  • SWTX $219,670,000.00
  • Revenue This Year
  • COLM $2.89
  • SWTX $74.36
  • Revenue Next Year
  • COLM $2.80
  • SWTX $75.63
  • P/E Ratio
  • COLM $15.56
  • SWTX N/A
  • Revenue Growth
  • COLM N/A
  • SWTX 730.42
  • 52 Week Low
  • COLM $58.44
  • SWTX $28.21
  • 52 Week High
  • COLM $92.88
  • SWTX $62.00
  • Technical
  • Relative Strength Index (RSI)
  • COLM 41.19
  • SWTX 63.41
  • Support Level
  • COLM $59.74
  • SWTX $46.74
  • Resistance Level
  • COLM $62.71
  • SWTX $46.92
  • Average True Range (ATR)
  • COLM 1.66
  • SWTX 0.11
  • MACD
  • COLM -0.12
  • SWTX -0.08
  • Stochastic Oscillator
  • COLM 21.30
  • SWTX 84.81

About COLM Columbia Sportswear Company

Columbia Sportswear Co makes outdoor and active-lifestyle apparel, footwear, equipment, and accessories that it sells under four primary brands: Columbia, Sorel, Mountain Hardwear, and prAna. The majority of sales are in the United States, but the company also has remarkable sales in its three other geographic segments: Latin American and Asia-Pacific; Europe, Middle East, and Africa; and Canada. The majority of sales are through wholesale channels, including sporting goods and department stores, but the company also operates its own branded stores in each of its geographic segments. Columbia sources products from around the world and uses contract manufacturers outside the United States, predominantly in Asia to manufacture its various products.

About SWTX SpringWorks Therapeutics Inc.

SpringWorks Therapeutics Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing, and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing prevalent, genetically defined cancers. OGSIVEO, the first commercial product, is a novel, oral, selective gamma-secretase inhibitor. GOMEKLI, the second commercial product, is an oral, small molecule mitogen-activated protein kinase, or MEK, inhibitor.

Share on Social Networks: